Tempest Therapeutics (TPST) Gross Margin (2015 - 2018)
Tempest Therapeutics' (TPST) quarterly Gross Margin came in at 20.0% in Q3 2018, down 2821.0% year-over-year from 0.74% in Q3 2017, and down 40.0% quarter-over-quarter from 33.33% in Q2 2018.
Powered by 
Analysis
Tempest Therapeutics (TPST) Gross Margin (2015 - 2018) Analysis & Trends
Tempest Therapeutics has disclosed Gross Margin across 4 years of filings, most recently posting 20.0% for Q3 2018.
- In Q3 2018, Gross Margin fell 2821.0% year-over-year to 20.0%; the TTM figure through Sep 2018 stood at 45.58% (up 47325.0% YoY), while the FY2017 annual figure was 167.8%, up 55931.0% from the prior year.
- Gross Margin came in at 20.0% for Q3 2018 at Tempest Therapeutics, down from 33.33% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 48.21% in Q3 2017 to a low of 1153.33% in Q3 2015.
- Average Gross Margin over 4 years is 393.52%, with a median of 286.67% recorded in 2015.
- Year-over-year, Gross Margin slumped 57215 bps in 2016 and jumped 94474 bps in 2017.
- Over 4 years, Gross Margin stood at 637.58% in 2015, then plunged by 70 bps to 1084.3% in 2016, then jumped by 87 bps to 139.56% in 2017, then soared by 114 bps to 20.0% in 2018.
- Per Business Quant data, the three most recent Gross Margin figures were 20.0% in Q3 2018, 33.33% in Q2 2018, and 67.16% in Q1 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.37 Bn | 112.79 Mn | 94.60% |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.65 Bn | 3.36 Bn | 55.72 Mn | 56.10% |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn | 64.90% |
| 5 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn | 94.01% |
| 6 | Beam Therapeutics | 2.55 Bn | 2.55 Bn | - | - |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn | 94.90% |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn | 62.77% |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn | 72.82% |
| 10 | Tempest Therapeutics | 3.35 Mn | 2.55 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2018 | 20.00% |
| Jun 30, 2018 | 33.33% |
| Mar 31, 2018 | -67.16% |
| Dec 31, 2017 | -139.56% |
| Sep 30, 2017 | 48.21% |
| Jun 30, 2017 | -226.19% |
| Mar 31, 2017 | -326.98% |
| Dec 31, 2016 | -1,084.30% |
| Sep 30, 2016 | -691.37% |
| Jun 30, 2016 | -552.38% |
| Mar 31, 2016 | -705.48% |
| Dec 31, 2015 | -637.58% |
| Sep 30, 2015 | -1,153.33% |
| Jun 30, 2015 | -286.67% |
| Mar 31, 2015 | -133.33% |